Skip to main content
SpringerLink
Log in

Liver transplantation for inborn errors of liver metabolism

  • SSIEM SYMPOSIUM 2005
  • Published:
Journal of Inherited Metabolic Disease

Summary

Liver transplantation brings complete recovery from end-stage liver disease, and full correction of liver based inborn errors of metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Cutillo L, Najimi M, Smets F, et al (2006) Safety of living related liver transplantation for progressive familial intrahepatic cholestasis. Pediatr Transplant (in press).

  • Darwish AA, Sokal E, Stephenne X, et al (2004) Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl 10: 1213–1215.

    Article  PubMed  Google Scholar 

  • Fox IJ, Chowdhury JR, Kaufman SS, et al (1998) Treatment of the Crigler–Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338: 1422–1426.

    Article  PubMed  CAS  Google Scholar 

  • Ganschow R, Grabhorn E, Schulz A, et al (2005) Long-term results of basiliximab induction immunosuppression in paediatric liver transplant recipients. Pediatr Transplant 9: 741–745.

    Article  PubMed  CAS  Google Scholar 

  • Goncalves I, Hermans D, Chretien D, et al (1995) Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J Hepatol 23: 290–294.

    PubMed  CAS  Google Scholar 

  • Jacquemin E, Hermans D, Myara A, et al (1997) Ursodeoxycholic acid therapy in paediatric patients with progressive familial intrahepatic cholestasis. Hepatology 25: 519–523.

    Article  PubMed  CAS  Google Scholar 

  • Jain AB, Marcos A, Pokharna R, et al (2005) Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation 80: 1692–1698.

    Article  PubMed  CAS  Google Scholar 

  • Kaibori M, Egawa H, Inomata Y, et al (1998) Strategy used to overcome graft atrophy in auxiliary partial orthotopic livertransplantation from a living donor for ornithine transcarbamylase deficiency. Transplant Proc 30: 3221–3222.

    Article  PubMed  CAS  Google Scholar 

  • Leonard JV (1995) The management and outcome of propionic and methylmalonic acidaemia. J Inherit Metab Dis 18: 430–434.

    Article  PubMed  CAS  Google Scholar 

  • Lerut JP, Ciccarelli O, Sempoux C, et al (2003) Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation. Transpl Int 16: 879–884.

    Article  PubMed  Google Scholar 

  • Nagarajan S, Enns GM, Millan MT, et al (2005) Management of methylmalonic acidaemia by combined liver-kidney transplantation. J Inherit Metab Dis 28: 517–524.

    Article  PubMed  CAS  Google Scholar 

  • Reding R, Gras J, Sokal E, et al (2003) Steroid-free liver transplantation in children. Lancet 362: 2068–2070.

    Article  PubMed  CAS  Google Scholar 

  • Reding R, Bourdeaux C, Gras J, et al (2004) The paediatric liver transplantation program at the Université catholique de Louvain. Acta Gastroenterol Belg 67: 176–178.

    PubMed  CAS  Google Scholar 

  • Rela M, Muiesan P, Vilca-Melendez H, et al (1999) Auxiliary partial orthotopic liver transplantation for Crigler–Najjar syndrome type I. Ann Surg 229: 565–569.

    Article  PubMed  CAS  Google Scholar 

  • Santos Silva EE, Sarles J, Buts JP, et al (1996) Successful medical treatment of severely decompensated Wilson disease. J Pediatr 128: 285–287.

    Article  PubMed  CAS  Google Scholar 

  • Saudubray JM, Touati G, Delonlay P, et al (1999) Liver transplantation in propionic acidaemia. Eur J Pediatr 158(Supplement 2): S65–S69.

    Article  PubMed  Google Scholar 

  • Scheers I, Bachy V, Stephenne X, et al (2005) Risk of hepatocellular carcinoma in liver mitochondrial respiratory chain disorders. J Pediatr 146: 414–417.

    Article  PubMed  Google Scholar 

  • Smets F, Sokal EM (2002) Epstein–Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management. Pediatr Transplant 6: 280–287.

    Article  PubMed  CAS  Google Scholar 

  • Smets F, Bodeus M, Goubau P, et al (2000a) Characteristics of Epstein–Barr virus primary infection in paediatric liver transplant recipients. J Hepatol 32: 100–104.

    Article  CAS  Google Scholar 

  • Smets F, Vajro P, Cornu G, et al (2000b) Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation. Transplantation 69: 982–984.

    Article  CAS  Google Scholar 

  • Smets F, Latinne D, Bazin H, et al (2002) Ratio between Epstein–Barr viral load and anti-Epstein–Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 73: 1603–1610.

    Article  PubMed  Google Scholar 

  • Sokal EM, Van Hoof F, Alberti D, et al (1992a) Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis. Eur J Pediatr 151: 200–203.

    Article  CAS  Google Scholar 

  • Sokal EM, Bustos R, Van Hoof F, et al (1992b) Liver transplantation for hereditary tyrosinemia – early transplantation following the patient's stabilization. Transplantation 54: 937–939.

    CAS  Google Scholar 

  • Sokal EM, Lopez-Silvarrey A, Buts JP, et al (1993a) Orthotopic liver transplantation for type I glycogenosis unresponsive to medical therapy. J Pediatr Gastroenterol Nutr 16: 465–467.

    Article  CAS  Google Scholar 

  • Sokal EM, Ulla L, Harvengt C, et al (1993b) Liver transplantation for familial hypercholesterolemia before the onset of cardiovascular complications. Transplantation 55: 432–433.

    CAS  Google Scholar 

  • Sokal EM, Silva ES, Hermans D, et al (1995) Orthotopic liver transplantation for Crigler–Najjar type I disease in six children. Transplantation 60: 1095–1098.

    PubMed  CAS  Google Scholar 

  • Sokal EM, Sokol R, Cormier V, et al (1999) Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr 158(Supplement 2): S81–S84.

    Article  PubMed  Google Scholar 

  • Sokal EM, Smets F, Bourgois A, et al (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76: 735–738.

    Article  PubMed  Google Scholar 

  • Stéphenne X, Najimi M, Smets F, et al (2005) Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 5: 2058–2061.

    Article  PubMed  Google Scholar 

  • Stéphenne X, Najimi M, Sibille C, Nassogne M, Smets F, Sokal EM (2006) Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology (in press).

  • Strom SC, Chowdhury JR, Fox IJ (1999) Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 19: 39–48.

    Article  PubMed  CAS  Google Scholar 

  • Van Maldergem L, Moser AB, Vincent MF, et al (2005) Orthotopic liver transplantation from a living-related donor in an infant with a peroxisome biogenesis defect of the infantile Refsum disease type. J Inherit Metab Dis 28: 593–600.

    Article  PubMed  Google Scholar 

  • van't Hoff W, McKiernan PJ, Surtees RA, et al (1999) Liver transplantation for methylmalonic acidaemia. Eur J Pediatr 158(Supplement 2): S70–S74.

    Article  Google Scholar 

  • Verloes A, Temple IK, Hubert AF, et al (1996) Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers. J Med Genet 33: 444–449.

    PubMed  CAS  Google Scholar 

  • Wanty C, Joomye R, Van Hoorebeek N, et al (2004) Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. Acta Gastroenterol Belg 67: 313–319.

    PubMed  CAS  Google Scholar 

  • Wendel U, Saudubray JM, Bodner A, et al (1999) Liver transplantation in maple syrup urine disease. Eur J Pediatr 158(Supplement 2): S60–S64.

    Article  PubMed  Google Scholar 

  • Yorifuji T, Kawai M, Mamada M, et al (2004) Living-donor liver transplantation for propionic acidaemia. J Inherit Metab Dis 27: 205–210.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. cliniques St Luc, Département de pédiatrie, Université catholique de Louvain, 10/1301 av Hippocrate, B-1200, Brussels, Belgium

    Efienne M. Sokal

Authors
  1. Efienne M. Sokal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Efienne M. Sokal.

Additional information

Communicating editor: Jean-Marie Saudubray

Competing interests: None declared

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sokal, E.M. Liver transplantation for inborn errors of liver metabolism. J Inherit Metab Dis 29, 426–430 (2006). https://doi.org/10.1007/s10545-006-0288-x

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-006-0288-x

Keywords

Search

Navigation